TNFRSF1A and central nervous system cancer: Furthermore, consistent with the above results, survival analyses and Cox regression analyses demonstrated that human patients with gliomas carrying high TNFRSF1A expression had a shorter OS or DFS than the low expression patients, and TNFRSF1A functioned as an independent prognostic indicator of OS.